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Abstract 
Background Intake of an edible blue-green alga Nostoc commune var. sphaeroides Kützing (N. commune) 
has been shown to lower plasma total cholesterol concentration, but the mechanisms behind the hy-
pocholesterolemic effect have not been elucidated.  Aim of the study To elucidate the mechanisms 
underlying the cholesterol-lowering effect of N. commune in mice.  Methods Male C57BL/6J mice were 
fed the AIN-93 M diet supplemented with 0 or 5% (wt/wt) dried N. commune for 4 weeks. Lipid levels 
in the plasma and liver, intestinal cholesterol absorption, and fecal sterol excretion were measured. 
Expression of hepatic and intestinal genes involved in cholesterol metabolism was evaluated by 
quantitative realtime PCR.  Results N. commune supplementation significantly reduced total plasma 
cholesterol and triglyceride concentrations by ~20% compared to controls. Intestinal cholesterol ab-
sorption was significantly decreased, while fecal neutral sterol output was significantly increased in 
N. commune–fed mice. mRNA levels of the cholesterol transporters such as Niemann Pick C1 Like 1, 
scavenger receptor class B type 1, ATP-binding cassette transporters G5 and A1 in small intestine 
were not significantly different between two groups. Hepatic lipid contents including total choles-
terol, triglyceride and free cholesterol in N. commune–fed mice were not significantly altered. How-
ever, the expression of cholesterol-modulating genes including sterol regulatory element binding 
protein-2 and 3-hydroxy-3-methylglutaryl coenzyme A reductase were significantly increased in 
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mice fed N. commune.  Conclusions N. commune supplementation exerted a hypocholesterolemic effect 
in mice, largely in part, by reducing intestinal cholesterol absorption and promoting fecal neutral 
sterol excretion. 
 
Keywords: blue-green algae, Nostoc commune var. sphaeroides Kützing, cholesterol metabolism, cho-
lesterol absorption 
 
Abbreviations: ABCA1, ATP-binding cassette transporter A1; ABCG5, ATP-binding cassette trans-
porter G5; CYP7A1, cholesterol-7α-hydroxylase; FAS, fatty acid synthase; GAPDH, glyceraldehyde 
3-phosphate dehydrogenase; HMGR, 3-hydroxy-3-methylglutaryl CoA reductase; LDLR, low-den-
sity lipoprotein receptor; N. commune, Nostoc commune var. sphaeroides Kützing; NPC1L1, Niemann 
Pick C1-Like 1; SR-B1, scavenger receptor class B, type 1; SREBP-1c, sterol regulatory element bind-
ing protein-1c; SREBP-2, sterol regulatory element binding protein-2 
 
Introduction 
 
Of all cardiovascular diseases, coronary heart disease (CHD) is the leading cause of death 
for both men and women worldwide. In particular, a positive correlation between death 
from CHD and total plasma cholesterol (TPC) level exceeding 200 mg/dl prompted the 
National Cholesterol Education Program (NCEP) to recommend TPC level to remain at 
200 mg/dl or lower for the general population [1]. Statin drugs are widely prescribed to 
lower TPC concentration. However, they can cause adverse effects such as liver dysfunc-
tion or myalgia [17, 27]. Lowering TPC through non-drug strategies, such as consuming 
foods containing bioactive compounds with hypocholesterolemic effects, would therefore 
be a desirable alternative. Many herbal and functional food supplements have been used 
for primary prevention of CHD. Soluble fibers from barley, beans, oat bran, and psyllium 
reduced TPC concentration when consumed by healthy hyperlipidemic patients on a low-
fat diet [21]. 
Recently, hypocholesterolemic and hypotriglyceridemic properties have been reported 
with intake of several strains of blue-green algae [20, 24, 36, 38]. Edible blue-green algae, 
such as Spirulina platensis and Aphanizomenon flosaquae, are currently marketed as dietary 
supplements with various health claims for immune function, inflammation, and heart 
disease. Spirulina platensis is harvested from controlled ponds around the world. In con-
trast, most of Aphanizomenon flosaquae products are harvested from the Upper Klamath 
Lake in southern Oregon in the United States, where it grows naturally. However, con-
cerns over naturally grown blue-green algae have been raised because they are easily con-
taminated with hepatotoxin-producing Microcystis aeruginosa as well as with heavy metals [14]. 
Nostoc commune var. sphaeroides Kützing (N. commune), an edible blue-green alga, is a 
cyanobacterium that has been grown and cultivated for medicinal uses for centuries. N. 
commune is the only edible species of Nostoc listed in the Compendium of Materia Medica, 
a Chinese medicinal work from 1596. N. commune is currently consumed where it is grown 
naturally in spherical macrocolonies in both terrestrial and aquatic habitats. It has been 
historically suggested that N. commune can treat a variety of medical conditions, including 
inflammation, night blindness, burns, anxiety, and chronic fatigue. Recent research has 
indicated that N. commune contains cryptophycin, a compound that inhibits cancer cell 
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growth [41], as well as antiviral compounds [12, 23]. A cholesterol-lowering effect of N. 
commune was reported in rats fed a high-cholesterol diet, the effects being attributed to its high 
fiber content [20]. Although studies have shown N. commune to confer health benefits, the 
investigation into the mechanisms behind the biological effects have been limited. We have 
previously shown that the lipid extract from N. commune exhibits potential cholesterol-
lowering properties due to its inhibitory effects on the maturation of sterol regulatory ele-
ment binding protein-2 (SREBP-2) and subsequent reduction of cholesterol synthesis in 
HepG2 cells, a human hepatoma cell line [33]. The purposes of this study were to deter-
mine a hypocholesterolemic effect of cultivated N. commune in vivo and to elucidate a 
mechanism for such an effect. We show here that consumption of N. commune lowered TPC 
concentration by reducing intestinal cholesterol absorption. 
 
Materials and methods 
 
Animal feeding and care 
Twenty-four C57BL/6J adult male mice (Jackson Laboratory) ranging in age from 11 to 24 
weeks were randomly assigned to control or N. commune supplement group and housed 
individually in a polycarbonate cage under a 12-h light/dark cycle. Initial body weight of 
mice were not significantly different between two groups (control, 27.9 g; N. commune, 27.8 
g; P = 0.96). Fresh N. commune obtained from Algaen Corporation (Winston-Salem, North 
Carolina, USA) was lypholyzed and stored at –80°C until it was finely ground and incor-
porated with the remaining diet ingredients. AIN-93 M diet [34, 35] was supplemented 
with 5% dried N. commune (wt/wt) at the expense of casein, cornstarch, and fiber on the 
basis of chemical composition of the alga (55.2% protein, 30% carbohydrate except fiber, 
8.5% fiber, 6% fat) as determined by Southern Testing and Research Laboratories (Wilson, 
North Carolina, USA; Table 1). Mice were fed an AIN-93 M control diet or N. commune 
supplemented diet for the 4-week experimental period with free access to food and water. 
Body weight and food intake were recorded weekly. At the end of the 4 weeks, mice were 
fasted for 4 h, anesthetized with ketamine HCl (50 mg/kg)/xylazine (10 mg/kg) and subse-
quently euthanized by cardiac puncture and cervical dislocation. Blood sample collected 
by cardiac puncture was put into a 2 ml tube containing 3.6 mg EDTA (BD Vacutainer). 
Blood was centrifuged for 20 min at 5,000 × g at 4°C to remove red blood cells, and plasma 
was stored at –80°C. Liver and intestine were immediately frozen in liquid nitrogen and 
stored at –80°C. All procedures were approved by the Institutional Animal Care and Use 
Committee of the University of Nebraska–Lincoln. 
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Table 1. AIN-93 M diet supplemented with 5% dry N. commune (wt/wt) 
Ingredient Control, g/kg diet 5% N. commune, g/kg diet 
Cornstarch 465.692 450.192 
Casein 140.000 110.000 
Dextrinized cornstarch 155.000 155.000 
Sucrose 100.000 100.000 
Soybean oil 40.000 40.000 
Fiber 50.000 45.500 
Mineral mix 35.000 35.000 
Vitamin mix 10.000 10.000 
L-Cystine 1.800 1.800 
Choline bitartrate 2.500 2.500 
Tert-butylhydroquinone 0.008 0.008 
Total 1000.000 1000.000 
 
N. commune safety assessment 
Plasma samples were analyzed for concentrations of alanine aminotransferase (ALT), as-
partate aminotransferase (AST), and blood urea nitrogen (BUN) at Kansas State Veterinary 
Diagnostic Laboratory (Manhattan, Kansas, USA). 
 
Plasma and liver lipids 
Lipid from liver samples was extracted using the method of Folch et al. [13] and solubilized 
in Triton X-100 as previously described [6]. Liver and plasma lipids were determined using 
reagents for total cholesterol (Roche Diagnostics), triglycerides (Roche Diagnostics), free 
cholesterol (Free Cholesterol E, Wako Chemicals), and phospholipid (Phospholipid C, 
Wako chemicals) by enzymatic analysis [5]. Liver esterified cholesterol was calculated as 
the difference between total and free cholesterol. 
 
Gene expression analysis 
Approximately 1.0 g of liver or proximal intestinal sample was homogenized (Tissue 
Tearor, Biospec Products) in 1 ml of TRIzol reagent (Invitrogen) for total RNA isolation 
following manufacturer’s protocol. Reverse transcription for cDNA synthesis and quanti-
tative realtime PCR analysis were performed as previously described [32, 33]. Primers 
were designed according to GenBank database using the Primer Express software (Ap-
plied Biosystems). The following primers were used for realtime PCR analysis: 3-hydroxy-
3-methylglutaryl coenzyme A reductase (HMGR), forward (5′-CCCAGTTGTGCGTCTT 
CCA-3′), reverse (5′-TTCGAGCCAGGCTTTCACTT-3′); low-density lipoprotein receptor 
(LDLR), forward (5′-ACTGGGTTGACTCCAAACTTCAC-3′), reverse (5′-GGTTGCCCCCG 
TTGACA-3′); fatty acid synthase (FAS), forward (5′-CGCTCGGCATGGCTATCT-3′), re-
verse (5′-CTCGTTGAAGAACGCATCCA-3′); cholesterol 7α hydroxylase (CYP7A1), for-
ward (5′-AGCAACTAAACAACCTGCCAGTACTA-3′), reverse (5′-GTCCGGATATTCAAG 
GATGCA-3′); sterol regulatory element binding protein 2 (SREBP-2), forward (5′-TCCGCC 
TGTTCCGATGTAC-3′), reverse (5′-TGCACATTCAGCCAGGTTCA-3′); scavenger recep-
tor class B type 1 (SR-B1), forward (5′-GATGTGGGCACCCTTCATG-3′), reverse (5′-CCG 
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GGCTGAAGAATTCCA-3′); Niemann Pick C1 Like 1 (NPC1L1), forward (5′-CGTCTG 
TCCCCGCCTATACA-3′), reverse (5′-CTAATGACACCAGCTGCTTGGT-3′); ATP-binding 
cassette transporter A1 (ABCA1), forward (5′-CGTTTCCGGGAAGTGTCCTA-3′), reverse 
(5′-GCTAGAGATGACAAGGAGGATGGA-3′); ATP binding cassette transporter G5 (ABCG5), 
forward (5′-CGTGGCGGACCAAATGA-3′), reverse (5′-GCTCGCCACTGGAAATTCC-3′); 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), forward (5′-GTGGTCTCCTCT 
GACTTCAACA-3′), reverse (5′-GTTGCTGTAGCCAAATTCGTTGT-3′). 
 
Cholesterol absorption efficiency 
Fractional intestinal cholesterol absorption was measured using dual-isotope method [3]. 
In brief, at week 3, mice were orally administered 17 μl of [3H]-β-sitostanol and [14C]-cholesterol 
(American Radiolabeled Chemicals) mixture in soybean oil for two consecutive days for 
an intake of 100,000 dpm of [3H]-β-sitostanol and [14C]-cholesterol each day. As our previ-
ous studies have shown that the majority of radiolabeled cholesterol is excreted at days 5–7, 
bedding and feces were collected at those days for analysis. Fecal sterol was extracted as 
previously described [39] and radioactivity was counted using a liquid scintillation coun-
ter (Packard). Cholesterol absorption efficiency was calculated as a % from the ratio of the 
two radiolabels in the dose and feces using the following equation: Percentage cholesterol 
absorption = [(14C/3H in dose-14C/3H in feces)/(14C/3H in dose)] × 100. 
 
Fecal sterols 
Fecal neutral and plant sterols were determined by gas chromatography, and acidic sterols 
were determined by enzymatic analysis using Wako Bile Acid Kit (Wako Chemicals). The 
procedures were previously described [39]. 
 
Statistical analysis 
Unpaired T-test was used to identify statistically significant differences between two 
groups with P < 0.05 considered significant by GraphPad InStat 3 (GraphPad Software, 
Inc.). Data are expressed as mean ± SEM. 
 
Results 
 
Safety of N. commune consumption 
Plasma levels of clinical indicators for tissue damage such as ALT, AST, and BUN were 
measured to determine the safety of N. commune consumption. ALT is often used as an 
indicator of liver damage, and AST, while it is also indicative of liver damage, is used to 
assess damage to other body organs. BUN is a byproduct of protein catabolism and is an 
indicator of kidney function. Plasma concentrations of AST, ALT, and BUN in N. commune–
fed mice were not significantly different from those of control group (data not shown). No 
significant differences in food intake between two groups were seen throughout the 4-week 
experiment (control, 4.2 g/day; N. commune, 4.0 g/ day; P > 0.05). Body weights of mice fed 
control or N. commune supplemented diet were not significantly different after 4-week di-
etary treatment (control, 30.3 g; N. commune, 29.2 g; P = 0.38). The data suggest that mice 
consuming 5% N. commune supplementation were healthy without manifesting signs of 
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toxicity from algal supplementation when they were on N. commune supplemented diet for 
a month. 
 
Effect of N. commune supplementation on plasma and liver lipids 
Five percent N. commune supplementation for 4 weeks significantly decreased plasma con-
centrations of total cholesterol and triglycerides as compared to the control group (Fig. 1). 
Despite the reduction of plasma lipid concentrations, no significant differences were seen 
in hepatic total cholesterol, triglyceride and phospholipid between the two groups (Table 2). 
Free and esterified cholesterol contents in the liver were not different in control and N. 
commune–fed mice (data not shown). 
 
 
 
Figure 1. Plasma total cholesterol and triglyceride concentrations were reduced in mice 
fed AIN-93 M diet supplemented with 5% dry N. commune (wt/wt). Plasma total choles-
terol triglyceride concentrations were determined by enzymatic analysis. Data are ex-
pressed as mmol/l. Points represent data from individual mice, and the horizontal lines 
denote the mean for each group, n = 12. 
 
Table 2. Liver weight and lipid contents in mice fed an AIN-93 M diet supplemented with 5% dry 
N. commune (wt/wt) for 4 weeks 
 
Liver weight, 
mg/g body wt 
Total cholesterol, 
μmol/g wet wt 
Triglyceride, 
μmol/g wet wt 
Phospholipid, 
μmol/g wet wt 
Control 41.89 ± 1.71 5.60 ± 0.30 34.56 ± 4.02 23.67 ± 0.85 
N. commune 36.64 ± 0.88* 5.88 ± 0.20 30.08 ± 3.75 23.97 ± 0.59 
Values represent mean ± SEM (n = 12) 
* Significantly different from control (P < 0.05) 
 
Alteration in hepatic gene expression by N. commune supplementation 
To evaluate whether N. commune supplementation altered the expression of genes in-
volved in cholesterol metabolism and transport in the liver, realtime PCR analysis was 
conducted utilizing GAPDH as a reference gene. A significant increase in mRNA abun-
dance of both SREBP-2 and HMGR was observed with N. commune supplementation com-
pared with control animals (Fig. 2). While LDLR mRNA was not significantly increased, a 
trend toward increase was seen in the N. commune–fed group (P = 0.098). In addition, a 
trend toward decrease in FAS (P = 0.061) was seen in mice fed N. commune. CYP7A1, the 
rate-limiting enzyme for bile acid biosynthesis, mRNA levels were significantly increased 
(P = 0.004) in N. commune–fed mice but its protein levels were not altered (data not shown). 
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Figure 2. mRNA abundance of hepatic genes were altered in mice fed an AIN-93 M diet 
supplemented with 5% dry N. commune (wt/wt). Total RNA was extracted from liver sam-
ples and realtime PCR analysis was performed to measure mRNA abundance. Data are 
expressed as fold change relative to control. Values are mean ± SEM, n = 12 
 
Inhibition of cholesterol absorption by N. commune 
Cholesterol absorption plays a major role in the regulation of whole body cholesterol ho-
meostasis [16, 45]. To determine if the hypocholesterolemic effect of N. commune is at least 
partly attributed to altered intestinal cholesterol absorption, cholesterol absorption effi-
ciency was assessed by a fecal dual-isotope ratio method. Cholesterol absorption efficiency 
in control mice was 80% while N. commune–fed mice exhibited a significant reduction at 
68% (Table 3), possibly accounting for the reduction in TPC concentration seen in these 
mice. The expression of the intestinal transporters known to be involved in cholesterol ab-
sorption such as NPC1L1, SR-BI, ABCG5, and ABCA1 were not significantly different be-
tween two groups (data not shown) [2, 19, 42]. 
 
Table 3. Cholesterol absorption and sterol excretion in mice fed an AIN-93 M diet supplemented 
with 5% dry N. commune (wt/wt) for 4 weeks 
 Cholesterol 
absorption, % 
Sterol output, μmol/day/100 g body wt 
Fecal neutral steroids Fecal bile acids Fecal plant sterols 
Control 79.53 ± 1.75 1.85 ± 0.11 4.06 ± 0.28 1.12 ± 0.13 
N. commune 67.87 ± 2.91* 3.14 ± 0.11* 4.15 ± 0.08 2.45 ± 0.06 
Values represent mean ± SEM (n = 8 for control, 9 for N. commune) 
* Significantly different from control (P < 0.05) 
 
Increased sterol excretion by N. commune supplementation 
Fecal sterol output was determined to investigate if N. commune supplementation could 
alter excretion of cholesterol and bile acid. As expected based on reduced cholesterol ab-
sorption in N. commune-fed mice, cholesterol output was increased more than two-fold 
with N. commune supplementation compared with controls (Table 3). Plant sterols includ-
ing campesterol, sitosterol, and stigmasterol were excreted significantly more in N. com-
mune-fed mice than controls. In contrast, output of acidic sterols, consisting of both bile 
acids and bile salts, remained unchanged between groups. Fecal output weight was also 
significantly increased in N. commune-fed mice (data not shown). 
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Discussion 
 
Consumption of foods containing bioactive compounds as an alternative or a supplement 
to prescription drugs is gaining in popularity. In this study, we sought to unveil mecha-
nisms for the cholesterol-lowering effects of N. commune. It was shown that intake of N. 
commune in rats reduced TPC concentration, which was attributed to the fiber component 
of the N. commune [20]. However, as N. commune used in that study was naturally grown, 
the macronutrient distribution would be unique to that harvest and would not be equated 
to the cultivated N. commune utilized in our study. Our results demonstrate that N. com-
mune, at 5% of the diet by weight, reduces TPC concentration by reducing intestinal cho-
lesterol absorption, providing a mechanism for the cholesterol-lowering effect in N. 
commune–fed mice. 
Intestinal cholesterol absorption is primarily protein-mediated. Several transporters 
have been suggested to directly or indirectly affect intestinal cholesterol absorption, in-
cluding NPC1L1, SR-BI, ABCA1, and ABCG5/G8. In particular, recent studies suggest a 
critical role of NPC1L1 in cholesterol and plant sterol absorption [2, 7, 37]. To determine if 
the reduction in cholesterol absorption by N. commune was due to a direct effect on these 
transporters, we measured mRNA abundance of intestinal cholesterol transporters such as 
NPC1L1, SR-B1, ABCG5, and ABCA1. There were no significant differences in the expres-
sion of the genes between control and N. commune–fed mice. Although we cannot rule out 
a possibility for the post-transcriptional regulation of the gene expression, the result sug-
gests that the reduced cholesterol absorption by N. commune appears to be attributed to its 
effect within the intestinal lumen without a direct effect on the expression of the cholesterol 
transporter genes. 
If cholesterol transporters do not directly play a role in the alteration of cholesterol ab-
sorption in N. commune–fed mice, an effect within the intestinal lumen may be occurring. 
Various dietary components have the capability to decrease cholesterol absorption includ-
ing plant sterols [28, 31] and soluble fiber [22, 43]. Soluble polysaccharide from red micro-
alga Porphyridium sp. and its biomass reduced serum cholesterol level in rats [10]. Even 
though the exact polysaccharide composition of N. commune is not known, compositional 
analysis of N. commune used in the current study revealed that it contained ~9% fiber. A 
significant increase in fecal output mass in N. commune–fed mice (data not shown) further 
supports a potential role of N. commune fiber in modulating the environment of the intes-
tinal lumen. Additionally, GC analysis revealed that dry N. commune contains 3.25 μg/g of 
sitosterol with no detectible amount of cholesterol. Therefore, we speculate the fiber and 
plant sterol in N. commune are responsible, at least in part, for the diminished intestinal 
cholesterol absorption. In addition to fiber and plant sterols, protein from plant sources 
may affect cholesterol absorption. C-phycocyanin, a phycobiliprotein in Spirulina plantensis 
with high levels of cystine, possesses hypocholesterolemic properties by reducing micellar 
solubility of cholesterol and cholesterol absorption, consequently increasing fecal neutral 
and acidic sterol output [29]. As N. commune is known to contain C-phycocyanin [15], it is 
possible that C-phycocyanin might contribute to the inhibition of cholesterol absorption 
by N. commune. In addition, the lipid fraction of N. commune equals ~6% of the dry weight. 
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Analysis by thin-layer chromatography and gas chromatography showed that approxi-
mately 15% of the lipid fraction consists of fatty acids, 75% of which are unsaturated fatty 
acids [32]. While these fatty acids may have potential anti-inflammatory properties, their 
low amount in the diet is unlikely to affect plasma cholesterol levels. 
Hepatic cholesterol synthesis is sensitive to the quantity of cholesterol that reaches the 
liver from the intestine via the chylomicron-remnant pathway [8]. While no significant 
changes in liver lipids were observed with N. commune supplementation, liver weights 
were significantly reduced in N. commune–fed mice, and a trend toward a decrease in he-
patic lipid content was seen. Gene expression analysis by realtime PCR indicated a signif-
icant increase in several cholesterol-modulating genes, including SREBP-2 and HMGR. 
When cellular cholesterol is depleted, SREBP-2 is activated to increase the transcription of 
genes involved in cholesterol biosynthetic pathway and uptake, including HMGR, LDLR, 
HMG-CoA synthase, farnesyl diphosphate synthase and squalene synthase [11, 18, 30]. 
The increase in SREBP-2 and subsequently HMGR expression observed with N. commune 
supplementation could have been the result of minor but sufficient enough changes in he-
patic cholesterol status to upregulate cholesterol synthesis for maintaining cholesterol ho-
meostasis. Additionally, we cannot rule out the possibility that free cholesterol content in 
subcellular compartments such as endoplasmic reticulum membrane, where SREBP-2 and 
HMGR reside, could be altered by N. commune without a change in total free cholesterol 
contents. 
LDLR is responsible for the uptake of LDL from circulation, and increased LDLR is as-
sociated with decreased plasma LDL cholesterol concentration [4]. Although it did not 
reach a statistical significance, N. commune–fed mice exhibited a slight increase in LDLR 
mRNA, which could contribute to the reduced TPC concentration. The decrease in TPC 
levels in N. commune–fed mice might also be due to its effect on a different aspect of lipo-
protein metabolism such as very low density lipoprotein (VLDL) metabolism. Fatty acid 
and triglyceride synthesis in the liver regulate the assembly and secretion of VLDL [9, 44]. 
Enzymes involved in fatty-acid synthesis and uptake, such as acetyl-CoA carboxylase, 
FAS, and stearoyl CoA desaturase, are under the transcriptional regulation of SREBP-1c 
[25, 26, 40]. FAS expression in N. commune–fed animals showed a trend toward decrease 
(P = 0.062). Potential inhibition of lipogenesis by N. commune may decrease VLDL for-
mation, which could reduce plasma concentrations of total cholesterol and triglyceride as 
seen in N. commune–fed animals. 
Inflammation and dyslipidemia are two major contributing factors involved in the pro-
gression of atherosclerosis. Lifestyle factors, including diet, influence atherosclerosis de-
velopment which leads to CHD as a significant cause of death worldwide. While drugs are 
commonly used to control dyslipidemia such as high plasma cholesterol and triglyceride 
levels, consumption of natural products for dietary regulation of plasma lipids are becom-
ing increasingly popular. Our previous research has shown N. commune lipid extract to 
have an anti-inflammatory effect in RAW 264.7 macrophages [32], as well as an inhibitory 
role in SREBP-1 and 2 maturation [33], indicating a potential athero-protective role of N. 
commune. Additionally, our current study indicates that whole N. commune supplementation 
decreases the absorption of cholesterol within the intestinal lumen, reducing TPC concen-
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tration. The combination of these beneficial effects of N. commune intake on lipid metabo-
lism may provide a beneficial alternative for lowering plasma cholesterol concentration in 
the human population. 
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